SE8002292L - 4-amino-3-kinolinkarboxylsyror och estrar som antisekretoriska anti-ulcerosa foreningar - Google Patents

4-amino-3-kinolinkarboxylsyror och estrar som antisekretoriska anti-ulcerosa foreningar

Info

Publication number
SE8002292L
SE8002292L SE8002292A SE8002292A SE8002292L SE 8002292 L SE8002292 L SE 8002292L SE 8002292 A SE8002292 A SE 8002292A SE 8002292 A SE8002292 A SE 8002292A SE 8002292 L SE8002292 L SE 8002292L
Authority
SE
Sweden
Prior art keywords
amino
esters
acids
compounds
secretoric
Prior art date
Application number
SE8002292A
Other languages
English (en)
Other versions
SE435837B (sv
Inventor
Jr H R Munson
R S Alphin
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of SE8002292L publication Critical patent/SE8002292L/sv
Publication of SE435837B publication Critical patent/SE435837B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8002292A 1979-03-26 1980-03-25 4-amino-3-kinolinkarboxylsyror och estrar derav med antisekretorisk och anti-ulceros aktivitet SE435837B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2398179A 1979-03-26 1979-03-26
US06/127,153 US4343804A (en) 1979-03-26 1980-03-04 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds

Publications (2)

Publication Number Publication Date
SE8002292L true SE8002292L (sv) 1980-09-27
SE435837B SE435837B (sv) 1984-10-22

Family

ID=26697875

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002292A SE435837B (sv) 1979-03-26 1980-03-25 4-amino-3-kinolinkarboxylsyror och estrar derav med antisekretorisk och anti-ulceros aktivitet

Country Status (31)

Country Link
US (1) US4343804A (sv)
JP (1) JPH02117663A (sv)
AR (1) AR230268A1 (sv)
AT (1) AT372373B (sv)
AU (1) AU528388B2 (sv)
BR (1) BR8001779A (sv)
CA (1) CA1147338A (sv)
CH (1) CH644105A5 (sv)
DE (1) DE3011490A1 (sv)
DK (1) DK156056C (sv)
EG (1) EG15009A (sv)
ES (1) ES489887A0 (sv)
FI (1) FI77452C (sv)
FR (1) FR2452485B1 (sv)
GB (1) GB2047244B (sv)
GR (1) GR68006B (sv)
HK (1) HK67983A (sv)
IE (1) IE49577B1 (sv)
IL (1) IL59628A (sv)
IN (1) IN151446B (sv)
IT (1) IT1133079B (sv)
MX (1) MX6264E (sv)
NL (1) NL8001752A (sv)
NO (1) NO153927C (sv)
NZ (1) NZ193252A (sv)
PH (1) PH16416A (sv)
PL (1) PL125030B1 (sv)
PT (1) PT71008B (sv)
SE (1) SE435837B (sv)
SG (1) SG33683G (sv)
YU (1) YU41702B (sv)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610981D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Quinoline amides
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5432182A (en) * 1989-02-23 1995-07-11 Smithkline Beecham Intercredit B.V. Compounds substituted quinoline derivatives
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
US5362743A (en) * 1993-03-09 1994-11-08 Pfizer Inc. Aminoquinoline derivatives
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
ATE197146T1 (de) * 1993-08-10 2000-11-15 Black James Foundation Gastrin-und cck-rezeptorligande
US5650415A (en) * 1995-06-07 1997-07-22 Sugen, Inc. Quinoline compounds
KR0169813B1 (ko) * 1995-07-12 1999-01-15 김종인 4-아미노-3-아실나프티리딘 유도체
US5760041A (en) * 1996-02-05 1998-06-02 American Cyanamid Company 4-aminoquinazoline EGFR Inhibitors
US6875769B2 (en) * 1996-05-23 2005-04-05 Pfizer Inc. Substituted6,6-hetero-bicyclicderivatives
US5929080A (en) * 1997-05-06 1999-07-27 American Cyanamid Company Method of treating polycystic kidney disease
US6251912B1 (en) 1997-08-01 2001-06-26 American Cyanamid Company Substituted quinazoline derivatives
US6323209B1 (en) 1997-11-06 2001-11-27 American Cyanamid Company Method of treating or inhibiting colonic polyps
BR9914164A (pt) 1998-09-29 2001-06-26 American Cyanamid Co Composto, método para o tratamento, inibição do crescimento de, ou erradiacação de um neoplasma, e de doença de rim policìstico, em um mamìfero em necessidade do mesmo, composição farmacêutica, e, processo para preparar um composto
KR100641802B1 (ko) * 1999-12-28 2006-11-02 에자이 가부시키가이샤 술폰아미드 함유 복소환 화합물
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6576644B2 (en) * 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US8293751B2 (en) 2003-01-14 2012-10-23 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
MXPA04008070A (es) 2003-03-10 2004-11-26 Altana Pharma Ag Novedoso proceso para la preparacion de roflumilasto.
AU2004257267B2 (en) * 2003-07-14 2009-12-03 Arena Pharmaceuticals,Inc Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
JP5383183B2 (ja) * 2005-03-16 2014-01-08 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング ロフルミラストを含有する矯味された剤形
WO2011022216A1 (en) * 2009-08-17 2011-02-24 High Point Pharmaceuticals, Llc Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
JP5856980B2 (ja) 2010-01-27 2016-02-10 アリーナ ファーマシューティカルズ， インコーポレイテッド （Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸およびその塩の調製のためのプロセス
KR101871011B1 (ko) 2010-09-22 2018-06-25 아레나 파마슈티칼스, 인크. Ｇｐｒ１１９ 수용체의 조절제 및 그와 관련된 장애의 치료
UA126268C2 (uk) 2015-01-06 2022-09-14 Арена Фармасьютікалз, Інк. СПОСОБИ ЛІКУВАННЯ СТАНІВ, ПОВ'ЯЗАНИХ З РЕЦЕПТОРОМ S1P<sub>1 </sub>
EA201890096A1 (ru) 2015-06-22 2018-08-31 Арена Фармасьютикалз, Инк. КРИСТАЛЛИЧЕСКАЯ L-АРГИНИНОВАЯ СОЛЬ (R)-2-(7-(4-ЦИКЛОПЕНТИЛ-3-(ТРИФТОРМЕТИЛ)БЕНЗИЛОКСИ)-1,2,3,4-ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛ-3-ИЛ)УКСУСНОЙ КИСЛОТЫ (СОЕДИНЕНИЯ 1) ДЛЯ ПРИМЕНЕНИЯ ПРИ РАССТРОЙСТВАХ, СВЯЗАННЫХ С S1P-РЕЦЕПТОРОМ
BR112019009529A2 (pt) * 2016-11-11 2019-07-30 Bayer Animal Health Gmbh novos derivados de quinolina
US11534424B2 (en) 2017-02-16 2022-12-27 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
WO2019084271A1 (en) * 2017-10-25 2019-05-02 Children's Medical Center Corporation PAPD5 INHIBITORS AND METHODS OF USE
PT3790874T (pt) 2018-05-09 2023-05-31 Bayer Animal Health Gmbh Derivados de quinolina antelmínticos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
JPS4838712A (sv) * 1971-09-18 1973-06-07

Also Published As

Publication number Publication date
GB2047244B (en) 1983-02-23
AU5684880A (en) 1980-10-02
YU41702B (en) 1987-12-31
DK156056B (da) 1989-06-19
ES8103048A1 (es) 1981-02-16
PT71008A (en) 1980-04-01
IT1133079B (it) 1986-07-09
NZ193252A (en) 1984-04-27
YU84480A (en) 1983-10-31
SG33683G (en) 1985-03-29
PT71008B (en) 1981-06-25
SE435837B (sv) 1984-10-22
FR2452485A1 (fr) 1980-10-24
CH644105A5 (fr) 1984-07-13
IL59628A0 (en) 1980-06-30
AR230268A1 (es) 1984-03-01
DE3011490A1 (de) 1981-03-12
US4343804A (en) 1982-08-10
DK156056C (da) 1989-11-06
FI800910A (fi) 1980-09-27
AU528388B2 (en) 1983-04-28
GR68006B (sv) 1981-10-26
ATA156480A (de) 1983-02-15
IE800605L (en) 1980-09-26
GB2047244A (en) 1980-11-26
AT372373B (de) 1983-09-26
IL59628A (en) 1983-06-15
BR8001779A (pt) 1980-11-18
FI77452C (sv) 1989-03-10
DK128380A (da) 1980-09-27
EG15009A (en) 1985-03-31
IN151446B (sv) 1983-04-23
JPH02117663A (ja) 1990-05-02
DE3011490C2 (sv) 1988-12-22
NL8001752A (nl) 1980-09-30
IE49577B1 (en) 1985-10-30
FI77452B (fi) 1988-11-30
PL125030B1 (en) 1983-03-31
NO153927B (no) 1986-03-10
NO153927C (no) 1986-06-18
CA1147338A (en) 1983-05-31
MX6264E (es) 1985-02-19
IT8067465A0 (it) 1980-03-26
PH16416A (en) 1983-09-29
FR2452485B1 (fr) 1986-09-12
PL222993A1 (sv) 1981-01-30
HK67983A (en) 1983-12-23
NO800858L (no) 1980-09-29
ES489887A0 (es) 1981-02-16

Similar Documents

Publication Publication Date Title
SE8002292L (sv) 4-amino-3-kinolinkarboxylsyror och estrar som antisekretoriska anti-ulcerosa foreningar
SE7906949L (sv) Nya spiro-oxazolidindioner
JPS5278848A (en) Preparation of novel propionic acid ester derivatives
AU5245379A (en) Pyrimido (6,1-a)isoquinolin-4-ones
ZA817696B (en) N-substituted omega-(2-oxo-4-imidazolin-1-yl)alcanoic acids,salts and esters thereof,process for producing the same and these active agents containing pharmaceutical compounds
ATE3634T1 (de) Adamantylalkyloxycarbonylderivate, deren herstellung und verwendung zur darstellung von peptiden.
SE8005714L (sv) Acetoximetyl-penamforeningar anvendbara som beta-laktamasinnibitorer
ATE43339T1 (de) Verfahren zur herstellung von optisch aktiven hydrochinonderivaten sowie von d-alphatocopherol.
SE8103778L (sv) Oxytocinanaloger och sett for framstellning derav
DK439082A (da) 4-acylamino-1-aza-adamantan-forbindelser samt fremgangsmaade til fremstilling deraf
SE7509764L (sv) Forfarande for framstellning av omega-nor-cykloalkyl-13,14-dehydro-prostaglandiner
JPS5225740A (en) Preparation of o-acyl-amidinophenols or acid addition salts thereof
JPS523046A (en) Prepration of 4-homotwistane-3-carboxylic acid esters
SE7903336L (sv) N-alkenylmoranolin-derivat
SE7906681L (sv) Ftalazonderivat
SE7902724L (sv) Substituerade n-iminometylpiperidiner
JPS5265263A (en) Azetidinone compounds
ES2130392T3 (es) Procedimiento para la preparacion de acido clavulanico.
SE7903971L (sv) Antitumordeoxiantracykliner
NO812630L (no) Fremgangsmaate for fremstilling av alfa-substituert ureidobenzylpenicillan-syre
JPS5210218A (en) Preparation of beta-sulfenylacrylamides
JPS5538363A (en) Preparation of optically active n-mercaptoacyl-imino acid
SE8502286D0 (sv) Estrar for framstellning av en beta-laktamasinhibitor
JPS51131857A (en) Process for preparation of substituted cyclopropanecarboxylic acid est ers
JPS5427594A (en) Penicillin derivative

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8002292-4

Effective date: 19921005

Format of ref document f/p: F